| |
| Issue |
Title |
| |
| Vol 11, No 4 (2021) |
Preparation of a Nonclinical Overview Based on Scientific Literature |
Abstract
PDF (Rus)
|
|
G. N. Engalycheva, R. D. Syubaev |
| |
| Vol 11, No 4 (2021) |
Methodological Approaches to Preclinical Evaluation of General Toxicity of Therapeutic Radiopharmaceuticals |
Abstract
PDF (Rus)
|
|
O. E. Klementyeva, A. S. Lunev, C. A. Lunyova |
| |
| Vol 11, No 3 (2021) |
Planning a Clinical Trial Programme for Medicinal Products for the Treatment of Axial Spondyloarthritis |
Abstract
PDF (Rus)
|
|
D. V. Goryachev |
| |
| Vol 11, No 2 (2021) |
Calculation of the Median Lethal Dose and Low Lethal Dose Using the CombiStats Biometric Software |
Abstract
PDF (Rus)
|
|
P. V. Shadrin, T. A. Batuashvili, L. V. Simutenko, N. P. Neugodova |
| |
| Vol 11, No 1 (2021) |
Planning a Clinical Development Programme for Medicines for Bronchial Asthma |
Abstract
PDF (Rus)
|
|
E. S. Petrova, D. V. Goryachev, A. D. Kuznetsova |
| |
| Vol 10, No 2 (2020) |
Methodological Approaches to Determination of Depressor Substances in Medicinal Products |
Abstract
PDF (Rus)
|
|
T. A. Batuashvili, L. V. Simutenko, N. P. Neugodova, P. V. Shadrin |
| |
| Vol 10, No 1 (2020) |
The Problem of Dynamic Process Manifestation in Identification of Organic Compounds by NMR Spectroscopy |
Abstract
PDF (Rus)
|
|
N. E. Kuz’mina, S. V. Moiseev, A. I Luttseva |
| |
| Vol 9, No 4 (2019) |
Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies) |
Abstract
PDF (Rus)
|
|
A. V. Sorokina, S. V. Alekseeva, N. V. Eremina, A. D. Durnev |
| |
| Vol 9, No 3 (2019) |
Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part I: Haematological Studies) |
Abstract
PDF (Rus)
|
|
A. V. Sorokina, S. V. Alekseeva, N. V. Eremina, A. D. Durnev |
| |
| 1 - 9 of 9 Items |
|
